1-Bromo-2-methoxy-4-phenylmethoxybenzene, 97%, 1g

5-Hydroxy-1-tetralone, 98.0%, 25g

3-((Tert-butoxycarbonyl)amino)phthalic acid, 97%, 500mg

3-(4-tert-Butyl-phenyl)-2-methyl-propan-1-ol, 95.0%, 1g

(3-Methyl-1H-pyrazolo[3,4-b]pyridin-5-yl)boronic acid, 97%, 2.5g

3,5-DIMETHOXYPYRIDIN-2-AMINE, 97.0%, 100mg

Disposable syringe Omnifix® with Luer connection, 30 ml, 100 pieces, 100 pieces

Imidazo[1,2-a]pyridine-3-carboxylic acid, 6-[5-[(phenylsulfonyl)amino]-3-pyridinyl]-, ethyl ester, 97%, 100mg

Ethanol, min. 80%, 1 l, plastic packaging.

(S)-6-(5-Bromo-1-((1r,4S)-4-methoxycyclohexyl)-1H-benzo[d]imidazol-2-yl)-1-(3,4-difluorophenyl)piperidin-2-one, 98%, 250mg

Sodium (6R,7R)-7-amino-3-(((6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, 97.0%, 10g

3-(3-Chlorophenyl)morpholine, 97%, 250mg

3-(4-Methylpyridin-3-yl)propan-1-ol, 95%, 1g